GnRH Analogues in Cancer and Human Reproduction
Volume III Benign and Malignant Tumours
Published on 28. October 2011
Book
Paperback/Softback
208 pages
978-94-010-6810-9 (ISBN)
Description
These four volumes comprlslng "GnRH Analogues in Cancer and Human Reproduction" are a distillation of the presentations of the invited speakers at a landmark International Symposium bearing the same name, organized by one of us (B. L. ) and held in Geneva, Switzerland in February 19B8. The Symposium was truly interdisciplinary spanning gonadal hormone dependent disease including various forms of cancer and ranging to control of fertility, both pro- and conception. The international flavor can be caught from the 480 participants and 259 contributors drawn from 14 countries. The Symposium, and therefore this book, would not have been possible without the backing of The International Committee for Research in Reproduction and the sponsorship of the International Society of Gynecologic Endocrinology, The Swiss Society of Fertility and Sterility, The University of Geneva School of Medicine, The Swiss Society of Endocrinology and The US Foundation for Studies in Reproduction Inc. , and help from the World Health Organization. B. H. Vickery B. Lunenfeld June 1989 xiii LIST OF CONTRIBUTORS TO THE SERIES A. Abbondante H. Bartermann First Institute of Obstetrics and Urologische Universitatsklinik Kiel Gynecology Arnold-Heller Strasse 7 University "La Sapienza" 0-2300 Kiel 1, FRG Rome,ltaly M. Bartholomew P. Abel Department of Medicine/Endocrinology Department of Urology Milton S. Hershey Medical Center Pennsylvania State University Hammersmith Hospital DuCane Road PO Box 850, Hershey, PA 17033, USA London W12 OHS, UK D. Beck H.
Reviews / Votes
` (These books) can be highly recommended; it should in fact be considered a serious lack if they are not present to complete the references on GnRH analogues. 'Annals of Oncology 2 (7) 1991
More details
Edition
Softcover reprint of the original 1st ed. 1990
Language
English
Place of publication
Dordrecht
Netherlands
Target group
Professional and scholarly
Research
Illustrations
208 p.
Dimensions
Height: 235 mm
Width: 155 mm
Thickness: 15 mm
Weight
394 gr
ISBN-13
978-94-010-6810-9 (9789401068109)
DOI
10.1007/978-94-009-0723-2
Schweitzer Classification
Other editions
Additional editions
B.H. Vickery | E. Lunenfeld
GnRH Analogues in Cancer and Human Reproduction
Volume III Benign and Malignant Tumours
Book
06/1990
Kluwer Academic Publishers
€85.55
Article exhausted; check different version
Content
1 The use of LHRH agonists in the treatment of uterine fibroids.- 2 Treatment of uterine fibroids with intra-nasal buserelin.- 3 Advances in the treatment of leiomyomata uteri with leuprolide.- 4 Relevance of an LHRH agonist to the treatment of uterine fibromyomas.- 5 Comparison of treatment of uterine leiomyomata with 3 different GnRH agonistic analogs.- 6 Sequential buserelin - medroxyprogesterone acetate treatment of uterine leiomyomata.- 7 Combined endoscopical and endocrinological treatment of uterine fibroids.- 8 Novel approaches to the treatment of advanced prostate cancer.- 9 Maximal androgen blockage in prostate cancer: today's therapy of choice and 5-year clinical experience.- 10 Medical versus surgical orchiectomy in advanced prostatic cancer.- 11 Orchiectomy versus total androgen blockade. A Phase III EORTC 30853 study.- 12 Towards the best treatment for advanced prostatic cancer.- 13 Clinical studies of leuprolide depot formulation in metastatic prostatic cancer.- 14 Treatment of advanced prostatic carcinomas by an LH RH analogue with or without an anti-androgen.- 15 The use of GnRH analogues in ovarian cancer.- 16 GnRH analogues in the treatment of ovarian carcinoma.- 17 Partial tumor remission in recurrent low malignant stromal endometriosis following GnRH agonist treatment.- 18 Endocrine, pharmacokinetic and clinical effects of LHRH analogue treatment in patients with malignant and benign breast disease.- 19 LHRH analogs as adjuncts to somatostatin analogs in the treatment of pancreatic cancer.- 20 An FSH producing tumor: response to GnRH analogue.